AU771275B2 - Treatment of diabetic nephropathy and microalbuminuria - Google Patents
Treatment of diabetic nephropathy and microalbuminuria Download PDFInfo
- Publication number
- AU771275B2 AU771275B2 AU40235/01A AU4023501A AU771275B2 AU 771275 B2 AU771275 B2 AU 771275B2 AU 40235/01 A AU40235/01 A AU 40235/01A AU 4023501 A AU4023501 A AU 4023501A AU 771275 B2 AU771275 B2 AU 771275B2
- Authority
- AU
- Australia
- Prior art keywords
- individual
- salviae miltiorrhizae
- diabetic
- level
- miltiorrhizae radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Medicines Containing Plant Substances (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/408,436 US6149915A (en) | 1999-09-29 | 1999-09-29 | Treatment of diabetic nephropathy and microalbuminuria |
| US09/408436 | 1999-09-29 | ||
| PCT/US2000/025783 WO2001022981A1 (en) | 1999-09-29 | 2000-09-21 | Treatment of diabetic nephropathy and microalbuminuria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4023501A AU4023501A (en) | 2001-04-30 |
| AU771275B2 true AU771275B2 (en) | 2004-03-18 |
Family
ID=23616291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU40235/01A Ceased AU771275B2 (en) | 1999-09-29 | 2000-09-21 | Treatment of diabetic nephropathy and microalbuminuria |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US6149915A (cg-RX-API-DMAC7.html) |
| EP (1) | EP1218020A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003510286A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1387439A (cg-RX-API-DMAC7.html) |
| AU (1) | AU771275B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2386000A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001022981A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6149915A (en) * | 1999-09-29 | 2000-11-21 | Shiva Biomedical, Llc | Treatment of diabetic nephropathy and microalbuminuria |
| DE10229180A1 (de) | 2002-06-28 | 2004-01-29 | Aventis Pharma Deutschland Gmbh | Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen |
| WO2005063232A1 (en) * | 2003-12-30 | 2005-07-14 | Md Bioalpha Co., Ltd. | Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity |
| US8029829B2 (en) | 2005-02-03 | 2011-10-04 | Taiyo Kagaku Co., Ltd. | Preventive, relieving or therapeutic composition for diabetes mellitus and/or diabetic nephropathy |
| CN100341581C (zh) * | 2005-07-29 | 2007-10-10 | 上海第二医科大学附属第九人民医院 | 一种丹酚酸b有效干预口腔癌动物模型的方法 |
| US20070027209A1 (en) * | 2005-08-01 | 2007-02-01 | Lee Hyun C | Prevention and treatment of atherosclerosis with lithospermate B |
| JP5169818B2 (ja) * | 2006-03-07 | 2013-03-27 | 日本新薬株式会社 | 育毛剤 |
| WO2008117901A1 (en) | 2007-03-28 | 2008-10-02 | Industry-Academic Cooperation Foundation, Yonsei University | A method for isolation of high concentration of magnesium lithospermate b from salviae miltiorrhizae |
| US9345732B2 (en) | 2009-11-19 | 2016-05-24 | Laila Nutraceuticals | Agents derived from Holoptelea integrifolia and their compositions for the control of metabolic syndrome and associated diseases |
| CN102550916A (zh) * | 2012-02-04 | 2012-07-11 | 王姗思 | 一种用于糖尿病肾病的食品 |
| CN102614267A (zh) * | 2012-04-24 | 2012-08-01 | 许风国 | 一种治疗糖尿病肾病的中药组合物及其制备方法 |
| CN103830496A (zh) * | 2014-02-28 | 2014-06-04 | 廊坊市思科农业技术有限公司 | 一种辅助降糖的组合物 |
| CN104974119B (zh) * | 2014-04-01 | 2018-10-19 | 中国科学院上海药物研究所 | 一种高纯度丹酚酸b镁及其制备方法 |
| CN104547498A (zh) * | 2014-12-31 | 2015-04-29 | 黎细乐 | 一种中药组合物的新用途 |
| US20160361288A1 (en) * | 2015-06-10 | 2016-12-15 | Postech Academy-Industry Foundation | Pharmaceutical compositions for preventing or treating diabetic nephropathy comprising the activity inhibitor of tenc1 |
| CN105311413A (zh) * | 2015-11-18 | 2016-02-10 | 暨南大学 | 治疗糖尿病肾病的含有艾叶的中药组合物及其制备方法 |
| CN107551172A (zh) * | 2017-10-26 | 2018-01-09 | 马雪英 | 一种治疗肾病综合症的药物及其制备方法 |
| CN110215449A (zh) * | 2019-05-13 | 2019-09-10 | 中国科学院长春应用化学研究所 | 紫草酸在抑制胰岛素淀粉样多肽聚集中的应用 |
| CN112190646B (zh) * | 2020-11-19 | 2021-12-28 | 首都医科大学附属北京中医医院 | 一种治疗糖尿病肾病的中药组合物及其制备方法 |
| CN112569313B (zh) * | 2020-12-28 | 2022-02-22 | 贵州三力制药股份有限公司 | 治疗肾病的中药组合物 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01268682A (ja) * | 1988-04-21 | 1989-10-26 | Minofuaagen Seiyaku Honpo:Goushi | 腎機能改善剤及びリソスペルミン酸塩の製造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5358962A (en) * | 1993-04-22 | 1994-10-25 | Minophagen Pharmaceutical Company | Antihypertensive method |
| JP3638967B2 (ja) * | 1993-06-03 | 2005-04-13 | 日本ケミカルリサーチ株式会社 | ネフローゼ症候群及び肝障害症状の寛解剤 |
| JP3161882B2 (ja) * | 1993-06-03 | 2001-04-25 | 日本ケミカルリサーチ株式会社 | 丹参由来多糖類、その製造法および用途 |
| FI943242A7 (fi) * | 1993-07-15 | 1995-01-16 | Jcr Pharmaceutical Co Ltd | Lääke munuais- ja maksatauteihin |
| US6149915A (en) * | 1999-09-29 | 2000-11-21 | Shiva Biomedical, Llc | Treatment of diabetic nephropathy and microalbuminuria |
-
1999
- 1999-09-29 US US09/408,436 patent/US6149915A/en not_active Expired - Fee Related
-
2000
- 2000-09-21 EP EP0096366100963661A patent/EP1218020A1/en not_active Withdrawn
- 2000-09-21 CN CN00815232A patent/CN1387439A/zh active Pending
- 2000-09-21 JP JP2001526191A patent/JP2003510286A/ja active Pending
- 2000-09-21 WO PCT/US2000/025783 patent/WO2001022981A1/en not_active Ceased
- 2000-09-21 US US09/666,623 patent/US6267992B1/en not_active Expired - Fee Related
- 2000-09-21 CA CA002386000A patent/CA2386000A1/en not_active Abandoned
- 2000-09-21 AU AU40235/01A patent/AU771275B2/en not_active Ceased
-
2001
- 2001-06-20 US US09/885,523 patent/US20020025347A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01268682A (ja) * | 1988-04-21 | 1989-10-26 | Minofuaagen Seiyaku Honpo:Goushi | 腎機能改善剤及びリソスペルミン酸塩の製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003510286A (ja) | 2003-03-18 |
| US6267992B1 (en) | 2001-07-31 |
| WO2001022981A1 (en) | 2001-04-05 |
| US6149915A (en) | 2000-11-21 |
| CA2386000A1 (en) | 2001-04-05 |
| AU4023501A (en) | 2001-04-30 |
| CN1387439A (zh) | 2002-12-25 |
| US20020025347A1 (en) | 2002-02-28 |
| EP1218020A1 (en) | 2002-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6267992B1 (en) | Treatment of diabetic nephropathy and microalbuminuria | |
| Gupta et al. | Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats | |
| Tang et al. | Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury | |
| Li et al. | Dexmedetomidine attenuates myocardial ischemia‐reperfusion injury in diabetes mellitus by inhibiting endoplasmic reticulum stress | |
| Yang et al. | Beneficial effects of ginsenoside-Rg1 on ischemia-induced angiogenesis in diabetic mice | |
| CN102091083B (zh) | 一种防治糖脂代谢紊乱的中药石油醚提取物及其制备方法 | |
| Adeyemi et al. | Hibiscus sabdariffa renews pancreatic β-cells in experimental type 1 diabetic model rats | |
| Zhou et al. | Chrysin improves diabetic nephropathy by regulating the AMPK‐mediated lipid metabolism in HFD/STZ‐induced DN mice | |
| CN113181150A (zh) | Sr1078在制备治疗酒精性肝损伤药物方面的应用、药物组合物 | |
| Zhang et al. | Tangduqing granules attenuate insulin resistance and abnormal lipid metabolism through the coordinated regulation of PPARγ and DGAT2 in type 2 diabetic rats | |
| Guo et al. | BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease | |
| Huang et al. | Ophiopogonin D ameliorates non‑alcoholic fatty liver disease in high‑fat diet‑induced obese mice by improving lipid metabolism, oxidative stress and inflammatory response | |
| CN102861201B (zh) | 一种治疗糖尿病的药物组合物及其制备方法 | |
| CN102631358A (zh) | 虎杖苷在制备糖尿病肾病治疗药物中的应用 | |
| CN114569613A (zh) | 蝙蝠葛生物碱类化合物在治疗代谢性疾病中的应用 | |
| CN119745925A (zh) | 肝组织源性细胞外囊泡在治疗酒精性肝疾病中的应用 | |
| Lv et al. | Network Pharmacology‐Based Approach to Explore the Total Flavonoids of Phellinus igniarius against Hyperuricemia via Regulating the Nrf2/HO‐1‐ROS‐ER Signaling Pathway | |
| CN119424436A (zh) | 化合物rociletinib通过抑制铁死亡在制备急性肝损伤的药物中的应用 | |
| Xu et al. | Effects of compound active peptides on protecting liver and intestinal epithelial cells from damages and preventing hyperglycemia | |
| Kurumatani et al. | Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study | |
| Wu et al. | Clerodendranthus spicatus-Cordyceps cicadae regulates mitophagy and protects renal tubular epithelial cells from hyperuricemic nephropathy | |
| Jiang et al. | Effects of 95% ethanol extract of Aquilaria sinensis leaves on hyperglycemia in diabetic db/db mice | |
| Oka et al. | Effect of Hachimijiogan against Renal Dysfunction and Involvement of Hypoxia‐Inducible Factor‐1α in the Remnant Kidney Model | |
| CN114848621A (zh) | 赖氨酸在制备用于抑制或治疗百草枯中毒的药物中的用途 | |
| CN120695051B (zh) | 狭苞橐吾醇提物在制备预防或治疗药物性肝损伤的药物中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |